Role of activated Rac1/Cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer.
Angiogenesis is a well-established target in anti-cancer therapy. Although vascular endothelial growth factor (VEGF)-mediated angiogenesis apparently requires the Rho GTPases Rac1 and Cdc42, the relevant mechanisms are unclear. Here, we determined that activated Rac1/Cdc42 in MCF-7 breast cancer cel...
Main Authors: | Ji Ma, Yan Xue, Wenchao Liu, Caixia Yue, Feng Bi, Junqing Xu, Jian Zhang, Yan Li, Cuiping Zhong, Yan Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3672132?pdf=render |
Similar Items
-
Correction: Role of Activated Rac1/Cdc42 in Mediating Endothelial Cell Proliferation and Tumor Angiogenesis in Breast Cancer
Published: (2013-01-01) -
Targeting Rac and Cdc42 GEFs in Metastatic Cancer
by: Maria del Mar Maldonado, et al.
Published: (2020-04-01) -
Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models
by: Anamaris Torres-Sanchez, et al.
Published: (2023-06-01) -
Optogenetic dissection of Rac1 and Cdc42 gradient shaping
by: S. de Beco, et al.
Published: (2018-11-01) -
RHOG Activates RAC1 through CDC42 Leading to Tube Formation in Vascular Endothelial Cells
by: Oula El Atat, et al.
Published: (2019-02-01)